Mrv0541 10301316452D 14 14 0 0 0 0 999 V2000 4.8159 -0.1948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.8159 -1.0199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.5304 -1.4324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.2448 -1.0199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.2448 -0.1948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.5304 0.2176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1014 -1.4324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3869 -1.0199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6725 -1.4324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3869 -0.1948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.9604 0.2176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.6748 -0.1948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.3893 0.2176 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 7.6748 -1.0199 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 0 2 3 1 0 0 0 0 3 4 2 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 1 6 1 0 0 0 0 2 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 8 10 1 0 0 0 0 5 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 12 14 2 0 0 0 0 M END > CHEBI:76158 > ibufenac > A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is replaced by a 4-isobutylphenyl group. Although it was shown to be effective in treatment of rheumatoid arthritis, the clinical use of ibufenac was discontinued due to hepatotoxic side-effects. > 3 > Ibunac; 4-Isobutylphenylacetic acid; 4-(2-Methylpropyl)benzeneacetic acid; (p-Isobutylphenyl)acetic acid > [4-(2-methylpropyl)phenyl]acetic acid; (4-isobutylphenyl)acetic acid > ibufenacum; ibufenaco; ibufenac > Dytransin > C12H16O2 > 192.25420 > 192.11503 > 0 > CC(C)Cc1ccc(CC(O)=O)cc1 > InChI=1S/C12H16O2/c1-9(2)7-10-3-5-11(6-4-10)8-12(13)14/h3-6,9H,7-8H2,1-2H3,(H,13,14) > CYWFCPPBTWOZSF-UHFFFAOYSA-N > 1553-60-2 > 2046683 > 1553-60-2 > D01963 > 1479559; 16456879; 21128314; 2585272; 3215965; 5329891; 5657238; 5748163; 5752436; 5807207; 687781; 7587932; 9061203 $$$$